R. Sieradzan

Gentamicin Stability with Ciprofloxacin in Human serum

R. Sieradzan, Ramona G. Boehler, 1988, Drug intelligence & clinical pharmacy.

Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study.

P. Cyr, D. Brixner, N. Sacks, 2019, Clinical therapeutics.

Injection Force Variability: An Overlooked Aspect of Proper Insulin Injection Technique

J. Goldman, R. Sieradzan, Alex Khzouz, 2021 .

Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational Study.

N. Pandya, R. Sieradzan, A. Trenery, 2023, Journal of the American Medical Directors Association.

Leveraging Partnerships to Reduce Insulin Needlestick Injuries

J. Gee, Rachael A. Katz, C. Jones, 2021, Journal of nursing care quality.

Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.

R. Sieradzan, D. R. Tucker, 1988, American journal of hospital pharmacy.

A multidisciplinary approach to enhance documentation of antibiotic serum sampling.

R. Sieradzan, A. Fuller, 1995, Hospital pharmacy.

Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States

G. Grunberger, David Sze, R. Sieradzan, 2020, Clinical Diabetes.

Addressing the Burden of Multiple Daily Insulin Injections in Type 2 Diabetes with Insulin Pump Technology: A Narrative Review

R. Sieradzan, J. R. Gavin, Diana Brixner, 2024, Diabetes therapy : research, treatment and education of diabetes and related disorders.